Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again. The agency handed down a green light to the medtech giant’s all-in ...

Now, all three are feeling more energetic with fewer, if any, episodes of atrial fibrillation since having a pulsed field ablation (PFA). “Before, I was so exhausted. I would just sleep and not ...

The VARIPULSE™ Platform is the first and only Pulsed Field Ablation (PFA) System in the U.S. fully integrated with the CARTO™ ...

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE™ Platform for the treatment of drug ...

which will combine to provide visualization for cardiac ablation procedures with the FARAPULSE Pulsed Field Ablation (PFA) System. Boston Scientific noted that the technologies are compatible ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...